Back to Search
Start Over
Characterization of Infectious Keratitis in Opioid Users in a County Hospital Setting.
- Source :
-
Cornea open [Cornea Open] 2023 Mar; Vol. 2 (1). Date of Electronic Publication: 2023 Mar 23. - Publication Year :
- 2023
-
Abstract
- Purpose: To determine risk factors and clinical course of corneal ulcers in the setting of opioid use.<br />Methods: A retrospective cohort study was performed of patients presenting with bacterial or fungal keratitis at a county hospital from 2010-2021. Subjects were separated into three groups: opioid drug users (heroin, methadone, fentanyl), non-opioid drug users, and non-drug users. 24 opioid users, 77 non-opioid drug users, and 38 non-drug users were included in the study. Chi-square and t-tests were used to compare hospitalization for corneal ulcer treatment; length of hospitalization; loss to follow-up; final best corrected visual acuity (BCVA); medication noncompliance; time to ulcer resolution; and visual disability (defined either by the legal limit for driving in California or the federal limit for blindness).<br />Results: Opioid users had higher rates of unemployment (p=0.002), homelessness (p=0.018), and psychiatric conditions (p=0.024) compared with non-opioid and non-drug users. They had more severe presentations, with worse initial BCVA of the affected eye (p=0.003), larger ulcer size (p=0.023), and higher rates of individuals below the legal vision thresholds for driving (p=0.009) and blindness (p=0.033) at initial presentation. Opioid use was associated with increased rate of hospitalization (p<0.001), higher fortified antibiotic use (p=0.009), worse final BCVA of the affected eye (p=0.020), and increased rates of BCVA worse than the legal vision thresholds for driving (p=0.043) and blindness (p<0.001) on final presentation.<br />Conclusions: Infectious keratitis associated with opioid use is associated with more severe presentations and poorer outcomes, including higher rates of visual disability.<br />Competing Interests: Conflicts of Interest: M.F.C. has consulted for Surrozen, Inc. and XCaliber Biotechnology, Inc. and is currently receiving a grant (R01EY032161) from the NIH/NEI. M.Y. has consulted for Iota Biosciences, Inc. G.D.S. has consulted for Dompé. For the remaining authors none were declared.
Details
- Language :
- English
- ISSN :
- 2833-6992
- Volume :
- 2
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Cornea open
- Publication Type :
- Academic Journal
- Accession number :
- 37637189
- Full Text :
- https://doi.org/10.1097/coa.0000000000000010